Delayed Berne S.E. Other stock markets | 5-day change | 1st Jan Change | ||
- CHF | -.--% | -.--% | -.--% |
Aug. 01 | Bank Stocks Lead European Equities Traded in the US as American Depositary Receipts Sharply Lower Thursday | MT |
Jul. 31 | GRIFOLS : Operational improvements continued in the Q2; guidance maintained |
14
Listed companies
19
Private companies
51
Insiders
Relation chart of related listed companies: Grifols, S.A.
Active Relations
Past Relations
Related listed companies: Grifols, S.A.
BIOTEST AG
Tomás Dagá Gelabert |
Raimon Grifols Roura |
David Bell |
SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.
Tomás Dagá Gelabert |
David Bell |
ALCON INC.
Thomas Heinrich Glanzmann
FAES FARMA, S.A.
Nuria Pascual Lapeña
ENSKILDA BANKEN
Anne-Catherine Berner
MEDICOVER AB
Anne-Catherine Berner
KUEHNE UND NAGEL INTERNATIONAL AG
Anne-Catherine Berner
PJT PARTNERS INC.
James Costos
OCUPHIRE PHARMA, INC.
Joseph Schachle
EUROAPI
Claire Giraut
FERROGLOBE PLC
Belén Villalonga Morenés
MELIA HOTELS INTERNATIONAL, S.A.
Carina Szpilka Lázaro
BANCO SANTANDER, S.A.
Luís Isasi Fernández de Bobadilla
LOGISTA HOLDINGS
Luís Isasi Fernández de Bobadilla
Active Relations
Past Relations
Relationship chart for related private companies: Grifols, S.A.
Active Relations
Past Relations
Related private companies: Grifols, S.A.
Grifols USA, Inc.
Medical Specialties
Víctor Grifols Roura |
Ramón Riera Roca |
Tomás Dagá Gelabert |
Raimon Grifols Roura |
Alfredo Arroyo Guerra |
Lafmin Morgan |
David Bell |
Grifols Diagnostic Solutions, Inc.
Pharmaceuticals: Major
Tomás Dagá Gelabert |
Raimon Grifols Roura |
Carsten Schroeder |
Probitas Foundation
Miscellaneous Commercial Services
Tomás Dagá Gelabert |
Raimon Grifols Roura |
Nuria Martín Barnés |
Aigües Minerals de Vilajuïga SA
Beverages: Non-Alcoholic
Raimon Grifols Roura |
Carlos Roura Fernandez |
Alfredo Arroyo Guerra |
Scranton Enterprises BV
Investment Managers
Víctor Grifols Roura |
Tomás Dagá Gelabert |
Biomat USA, Inc.
Medical/Nursing Services
Tomás Dagá Gelabert |
David Bell |
Grifols Canada Therapeutics, Inc.
Pharmaceuticals: Major
Tomás Dagá Gelabert |
Daniel Fleta Coit |
Osborne Clarke
Miscellaneous Commercial Services
Tomás Dagá Gelabert |
Nuria Martín Barnés |
Grifols UK Ltd.
Medical Distributors
Montserrat Lloveras Calvo |
Alfredo Arroyo Guerra |
BPC Plasma, Inc.
Pharmaceuticals: Major
Tomás Dagá Gelabert |
David Bell |
Joaquim Molins Figueras Foundation
Tomás Dagá Gelabert |
Nuria Martín Barnés |
Alkahest, Inc.
Biotechnology
Tomás Dagá Gelabert |
David Bell |
Araclon Biotech SL
Miscellaneous Commercial Services
Tomás Dagá Gelabert |
Victor Grifols Deu |
Grifols, Inc.
Pharmaceuticals: Major
Thomas Heinrich Glanzmann |
Lafmin Morgan |
Progenika Biopharma SA
Medical Specialties
Ramón Riera Roca |
Tomás Dagá Gelabert |
Tojosnura SL
Miscellaneous Commercial Services
Tomás Dagá Gelabert |
Nuria Martín Barnés |
Instituto Grifols SA
Pharmaceuticals: Other
Víctor Grifols Roura |
Ramón Riera Roca |
Raimon Grifols Roura |
Arrahona Optimus SL
Real Estate Development
Víctor Grifols Roura |
Raimon Grifols Roura |
Grifols Canada Ltd.
Pharmaceuticals: Major
Víctor Grifols Roura |
Raimon Grifols Roura |
Active Relations
Past Relations
Connection statistics
Active
Inactive
Listed companies
Private companies
Activities of related companies
Pharmaceuticals: Major | 7 |
Miscellaneous Commercial Services | 4 |
Medical Specialties | 3 |
Biotechnology | 3 |
Medical/Nursing Services | 2 |
Major Banks | 2 |
Pharmaceuticals: Other | 2 |
Real Estate Development | 1 |
Medical Distributors | 1 |
Investment Managers | 1 |
Countries of related companies
Spain | 13 |
United States | 8 |
Canada | 2 |
United Kingdom | 2 |
Sweden | 2 |
Switzerland | 2 |
Netherlands | 1 |
France | 1 |
China | 1 |
Germany | 1 |
Company Profile
Grifols, S.A. specializes in the research, development, manufacturing and marketing of therapeutic products and medical devices for use in hospitals and medical analysis laboratories. Net sales break down by family of products and services as follows:- products derived from plasma (84.3%): products for use by the pharmaceutical and biotechnology industries;- diagnostic machines and reagents (10.2%): in vitro hemophilic diagnostic equipment, coagulation analyzers, infectious serology reagents, etc. for use primarily by blood banks and transfusion centers;- hospital products (2.4%): non-biological surgical products, radiology and nutritional products, etc. for use by hospital pharmacies;- other (3.1%): primarily intermediate biological products and subcontracted manufacturing services.Net sales are distributed geographically as follows: Spain (5.5%), European Union (13.6%), the United States and Canada (59.1%) and other (21.8%).
Employees
Sector
Pharmaceuticals
Calendar
2024-10-09 - Investors Day
Related indices
IBEX 35
More about the company
- Stock Market
- Equities
- GRF Stock
- OZTA Stock
- Company Grifols, S.A.
- Connections